30 October 2019
Prioritis has launched its PrismHEOR platforms reinforcing its unique offer of daily, intelligent and reliable published and upcoming data regarding pharmaceutical HTA and reimbursement decisions.......
Prismaccess contains a comprehensive, detailed record of HTA authorities’ decisions extracted into easy to navigate summaries.
Prismaccess allows you to identify key data and comparator products performances allowing you to build your Pricing & Reimbursement dossier in accordance with the needs of the regulators and payers.
Prismaccess provides data and information on all pharma & biotech products during initial and subsequent evaluations by national authorities on HTA markets.
Prioritis is a global provider in market access solutions for pharmaceutical, biotechnology and medical devices. Prioritis undertakes support for pricing and reimbursement processes for new innovative drugs, extension of indications and reassessment of therapeutic areas.
Evalumade is a platform dedicated to market access leaders, offering clear top-level visual information about HTA decisions. It is a unique responsive, graphical interface constructed to facilitate the consultation and the extraction of HTA data.